NO20004141D0 - Nye substituerte pyridinoarylpiperaziner er anvendelige ved behandling av benign prostatahyperplasi - Google Patents

Nye substituerte pyridinoarylpiperaziner er anvendelige ved behandling av benign prostatahyperplasi

Info

Publication number
NO20004141D0
NO20004141D0 NO20004141A NO20004141A NO20004141D0 NO 20004141 D0 NO20004141 D0 NO 20004141D0 NO 20004141 A NO20004141 A NO 20004141A NO 20004141 A NO20004141 A NO 20004141A NO 20004141 D0 NO20004141 D0 NO 20004141D0
Authority
NO
Norway
Prior art keywords
pyridinoarylpiperazines
useful
treatment
benign prostate
prostate hyperplasia
Prior art date
Application number
NO20004141A
Other languages
English (en)
Other versions
NO20004141L (no
NO317103B1 (no
Inventor
Gee-Hong Kuo
William V Murray
Catherine P Prouty
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20004141D0 publication Critical patent/NO20004141D0/no
Publication of NO20004141L publication Critical patent/NO20004141L/no
Publication of NO317103B1 publication Critical patent/NO317103B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20004141A 1998-02-20 2000-08-18 Nye substituerte pyridino arylpiperaziner er anvendelige ved behandling av benign prostata hyperplasi NO317103B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7532198P 1998-02-20 1998-02-20
PCT/US1999/003608 WO1999042448A1 (en) 1998-02-20 1999-02-19 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia

Publications (3)

Publication Number Publication Date
NO20004141D0 true NO20004141D0 (no) 2000-08-18
NO20004141L NO20004141L (no) 2000-10-19
NO317103B1 NO317103B1 (no) 2004-08-09

Family

ID=22124955

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004141A NO317103B1 (no) 1998-02-20 2000-08-18 Nye substituerte pyridino arylpiperaziner er anvendelige ved behandling av benign prostata hyperplasi

Country Status (23)

Country Link
US (1) US6218396B1 (no)
EP (1) EP1054868B1 (no)
JP (1) JP2002503724A (no)
KR (1) KR100591028B1 (no)
CN (1) CN1121390C (no)
AR (1) AR014626A1 (no)
AT (1) ATE250580T1 (no)
AU (1) AU766398B2 (no)
BR (1) BR9909647A (no)
CZ (1) CZ294136B6 (no)
DE (1) DE69911582T2 (no)
DK (1) DK1054868T3 (no)
ES (1) ES2209468T3 (no)
HU (1) HUP0100781A3 (no)
IL (2) IL137954A0 (no)
NO (1) NO317103B1 (no)
NZ (1) NZ506462A (no)
PL (1) PL342339A1 (no)
PT (1) PT1054868E (no)
TR (1) TR200003220T2 (no)
TW (1) TW565555B (no)
WO (1) WO1999042448A1 (no)
ZA (1) ZA991315B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7366998A (en) * 1997-05-12 1998-12-08 Ortho-Mcneil Pharmaceutical, Inc. Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
CZ2003686A3 (cs) 2000-08-08 2003-08-13 Ortho Mcneil Pharmaceutical, Inc. Neimidazolové aryloxypiperidiny
CA2471760A1 (en) * 2001-12-28 2003-07-17 Takeda Chemical Industries, Ltd. Preventives/remedies for urinary disturbance
USD545208S1 (en) 2006-09-27 2007-06-26 001 Corporation Perfume bottle and cap
JP5483880B2 (ja) * 2006-10-23 2014-05-07 武田薬品工業株式会社 イミノピリジン誘導体およびその用途
KR20100130235A (ko) * 2008-04-23 2010-12-10 다케다 야쿠힌 고교 가부시키가이샤 이미노피리딘 유도체 및 이의 용도
US20110039892A1 (en) * 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
CN103980195A (zh) * 2014-04-28 2014-08-13 广州医科大学 酰胺类苯基哌嗪衍生物及其盐与在制备治疗良性前列腺增生症药物中的应用
CN108530391B (zh) * 2018-05-17 2022-05-17 袁牧 一种酰胺类芳基哌嗪衍生物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2027898A6 (es) * 1991-01-24 1992-06-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina.
US5403847A (en) 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US5688795A (en) 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
AU8130298A (en) * 1997-07-15 1999-02-10 Sankyo Company Limited Piperazine derivatives

Also Published As

Publication number Publication date
KR20010041115A (ko) 2001-05-15
NO20004141L (no) 2000-10-19
IL137954A (en) 2007-06-03
DE69911582T2 (de) 2005-09-15
HUP0100781A2 (hu) 2001-08-28
IL137954A0 (en) 2001-10-31
NZ506462A (en) 2003-07-25
HUP0100781A3 (en) 2002-12-28
NO317103B1 (no) 2004-08-09
AU766398B2 (en) 2003-10-16
AR014626A1 (es) 2001-03-28
PT1054868E (pt) 2004-01-30
JP2002503724A (ja) 2002-02-05
CZ294136B6 (cs) 2004-10-13
US6218396B1 (en) 2001-04-17
PL342339A1 (en) 2001-06-04
TR200003220T2 (tr) 2001-04-20
KR100591028B1 (ko) 2006-06-22
CZ20003044A3 (cs) 2001-04-11
BR9909647A (pt) 2000-11-21
ATE250580T1 (de) 2003-10-15
ZA991315B (en) 2000-11-20
DE69911582D1 (de) 2003-10-30
EP1054868A1 (en) 2000-11-29
TW565555B (en) 2003-12-11
HK1030776A1 (en) 2001-05-18
ES2209468T3 (es) 2004-06-16
AU3302599A (en) 1999-09-06
EP1054868B1 (en) 2003-09-24
CN1121390C (zh) 2003-09-17
DK1054868T3 (da) 2003-12-22
WO1999042448A1 (en) 1999-08-26
CN1291188A (zh) 2001-04-11

Similar Documents

Publication Publication Date Title
NO993396L (no) Kinolin- og kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi
DE60023982D1 (de) System zur Behandlung von benigner Prostatahyperplasie
BR9608651A (pt) Método para o tratamento de hiperplasia prostática benigna com terapia térmica
NO20025792L (no) Kinazolinderivater for behandling av tumorer
NO992069L (no) Konjugater som kan anvendes ved behandling av prostatakreft
DK0925069T3 (da) Anvendelse af Cetrorelix til behandling af godartet prostatahypertrofi og prostatacancer
AU1316000A (en) Compositions and methods for treating benign prostatic hyperplasia using tocotrienols
DE19983141T1 (de) Vernetzbare Zusammensetzung und daraus erhältlicher vernetzter Gegenstand
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
EP1320376A4 (en) TREATMENT OF PROSTATE CANCER
NO20022245D0 (no) Onkolyttiske kombinasjoner for behandling av cancer
NO20002804D0 (no) Konjugater som kan anvendes ved behandling av prostatakreft
NO995518D0 (no) Arylsubstituerte piperaziner brukbare ved behandling av benign prostatisk hyperplasi
NO20004141L (no) Nye substituerte pyridino arylpiperaziner er anvendelige ved behandling av benign prostata hyperplasi
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
NO20004142D0 (no) Ftalimidoarylpiperaziner som <alfa> 1A reseptorantagonister anvendelige ved behandling av benign prostatahyperplasi
NO20010569D0 (no) Proteaseinhibitorer for anvendelse ved behandling av psoriasis
NO975838D0 (no) Melatoninagonister for behandling av godartet prostatisk hyperplasi
NO20005062D0 (no) Behandling av panikkanfall
AU1036701A (en) Use of acetyl salicilyc acid for the treatment of benign prostate hyperplasia
GB9810895D0 (en) Combination therapy for the treatment of benign prostatic hyperplasia
GB9602903D0 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
NO996166D0 (no) Fremgangsmåte for behandling av avluter
FI980169A0 (fi) Foerfarande och anordning foer anrikning av molekyler och joner

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees